Literature DB >> 3300459

Immediate hypersensitivity reactions to beta-lactam antibiotics.

A Saxon, G N Beall, A S Rohr, D C Adelman.   

Abstract

Allergic reactions to the beta-lactam antibiotics (penicillins, cephalosporins, carbapenems, and monobactams) are a major factor limiting their use. Immediate hypersensitivity reactions to penicillins depend on the presence of preformed allergic (IgE) antibodies to several penicillin determinants. These materials can be used in in-vivo skin testing to exclude those patients at risk for immediate or accelerated allergic reactions. The cephalosporins have not had their relevant determinants defined as related to allergic reactions. The results of in-vivo challenges of patients with IgE to penicillin suggest the incidence of reactivity of cephalosporins in patients allergic to penicillin is less than generally appreciated. The monocyclic beta-lactam antibiotic, aztreonam (a monobactam), failed to show cross-reactivity with penicillin antibodies, because immune reactivity toward the monobactam was directed against side chain rather than nuclear determinants. On the other hand, the new bicyclic carbapenem beta-lactam drugs, represented by imipenem, showed extensive in-vivo cross-reactivity with penicillins.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3300459     DOI: 10.7326/0003-4819-107-2-204

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  43 in total

1.  Prevention of adverse events in hospitalized patients using an antimicrobial review program.

Authors:  B J Guglielmo; A D Luber; R L Corelli; J F Flaherty; R A Jacobs
Journal:  West J Med       Date:  1999-09

Review 2.  Recognising antibacterial hypersensitivity in children.

Authors:  A Romano
Journal:  Paediatr Drugs       Date:  2000 Mar-Apr       Impact factor: 3.022

Review 3.  Joining the DoTS: new approach to classifying adverse drug reactions.

Authors:  J K Aronson; R E Ferner
Journal:  BMJ       Date:  2003-11-22

Review 4.  Diagnosis and management of anaphylaxis.

Authors:  Anne K Ellis; James H Day
Journal:  CMAJ       Date:  2003-08-19       Impact factor: 8.262

5.  Legal obligation of physicians to disclose information to patients.

Authors:  D I Hammond
Journal:  CMAJ       Date:  1991-06-15       Impact factor: 8.262

Review 6.  Clarification of terminology in drug safety.

Authors:  Jeffrey K Aronson; Robin E Ferner
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

7.  Cross-reactivity of beta-lactam antibiotics.

Authors:  C W James; C Gurk-Turner
Journal:  Proc (Bayl Univ Med Cent)       Date:  2001-01

Review 8.  Antibiotic hypersensitivity in patients with CF.

Authors:  Sujatha Ramesh
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

9.  Optimizing empiric antibiotic therapy in patients with severe β-lactam allergy.

Authors:  Lindsey P Koliscak; James W Johnson; James R Beardsley; David P Miller; John C Williamson; Vera P Luther; Christopher A Ohl
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

10.  Allergies in children.

Authors:  Z Chad
Journal:  Paediatr Child Health       Date:  2001-10       Impact factor: 2.253

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.